Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...
Dopamine levels drive the vigor of our movements, explaining why we move faster and with more energy when we are happy or ...
In a recent study published in Nature Neuroscience, a group of researchers explored how the cerebellum directly affects dopamine release in the substantia nigra compacta (SNc). While the cerebellum's ...
Add Yahoo as a preferred source to see more of our stories on Google. pair of feet A condition that compels people to move their legs could indicate they have a greater chance of developing ...
Post hoc analyses of two Phase 2 trials examine the potential benefits of solengepras, a once-daily, oral, non-dopaminergic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results